[1]Effect of bevacizumab combined with chemotherapy on circulating endothelial cell in patients with advanced colorectal cancer[J].Chinese Journal of Clinical Oncology and Rehabilitation

[2]GUO Jing-jing,ZHENG Qin.Efficacy and safety of bevacizumab plus chemotherapy for advanced colorectal cancer[J].Chinese Journal of Biochemical Pharmaceutics,2012,33(6):892-893.

[3]Larsen Finn Ole,Boisen Mogens Karsbøl,Fromm Annelene L,Jensen Benny Vittrup.Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer[J].Acta oncologica (Stockholm, Sweden),2012,51(2):231-233.

[4]Yong Sang Hong,Jeeyun Lee,Kyu-pyo Kim,Jae-Lyun Lee,Young Suk Park,Joon Oh Park,Se Hoon Park,Sun Young Kim,Ji Yeon Baek,Jee Hyun Kim,Keun-Wook Lee,Tae-You Kim,Tae Won Kim.Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy[J].Investigational new drugs,2013,31(1):183-191.

[5]Zhao Yuan-Yuan,Xue Cong,Jiang Wei,Zhao Hong-Yun,Huang Yan,Feenstra Kristin,Resau James H,Qian Chao-Nan,Zhang Li.Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab[J].Journal of thoracic oncology,2012,7(1):71-75.

[6]LU Zhen-duo,LIU Zhen-zhen,CUI Shu-de Breast Diseases Center,Cancer Hospital Affiliated to Zhengzhou University,Zhengzhou ,China.Expression of microvascular density evaluates prognosis of patients with breast cancer[J].Journal of Medical Forum,2011(17):32-34,38.

[7]FU Hongwei,SUN Tao,JING Mingxi.Clinical observation of bevacizumab plus chemotherapy for advanced gastric cancer[J].Journal of International Pathology and Clinical Medicine,2013,33(1):42-46.

[8]ZHAO Jing,ZHANG Wen,LI Wen-hua,ZHU Dan.Clinical observation of bevacizumab plus chemotherapy for advanced colorectal cancer[J].China Oncology,2011,21(10).

[9]Oral anti-angiogenesis treatment plus chemotherapy is not more efficacious than bevacizumab plus chemotherapy in metastatic colorectal cancer[J].Oncology (Williston Park, N.Y.)

[10]Wang Ming,Zheng Xiaofeng,Ruan Xiaojiao,Ye Bailiang,Cai Long,Lin Feizhuan,Tu Jinfu,Jiang Feizhao and Li Shaotang.Efficacy and safety of first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a meta-analysis[J].Chinese medical journal,2014,127(3):538-546.

[11]谢剑明,谢亚琳,陈锦章,李黎波,廖旺军.Effect of bevacizumab combined with FOLFOX4 on advanced colorectal cancer[J].China Tropical Medicine,2010,10(11):1393-1394.

[12]J. Garde-Noguera,M. Gil-Raga,E. Evgenyeva,J. A. García,A. Llombart-Cussac,C. Camps-Herrero.High pKDR immunohistochemical expression is an unfavourable prognostic biomarker in patients with advanced colorectal cancer treated with chemotherapy plus bevacizumab[J].Clinical & translational oncology,2016,18(4):405-412.

[13]E Zulato,F Bergamo,A De Paoli,G Griguolo,G Esposito,G L De Salvo,C Mescoli,M Rugge,M Nardin,L Di Grazia,S Lonardi,S Indraccolo,V Zagonel.Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab[J].British journal of cancer,2014,111(1):25-32.

[14]Yunfei Cao,Aihua Tan,Feng Gao,Lidan Liu,Cun Liao,Zengnan Mo.A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer[J].International journal of colorectal disease,2009,24(6):677-685.

[15]Zhang Ninggang,Wang Yusheng,Zhang Chenyan,Li Xiuxiu,Chen Xiangyu,Wen Lu.Efficacy and safety of bevacizumab plus chemotherapy in treatment of patients with metastatic colorectal cancer[J].Cancer Research and Clinic,2014(11):741-743.

[16]Xia Xueming;Mao Zhiyuan;Bai Li.The efficacy of bevacizumab plus bi-weekly chemotherapy for patients with advanced colorectal cancer as first-line treatment and the relationship with K-ras gene[J].Journal of Modern Oncology,2015(8):1090-1093.

[17]Park Se Hoon,Bang Soo-Mee,Cho Eun Kyung,Baek Jeong Heum,Oh Jae Hwan,Im Seock Ah,Park Young Suk,Shin Dong Bok,Lee Jae Hoon.First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer[J].Oncology,2004,66(5):353-357.

[18]Hurwitz Herbert.Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer[J].Clinical colorectal cancer,2004,4(Z2):S62-S68.

[19]Wei Wang;Li-Rong Zhao;Xiu-Qiang Lin;Fen Feng;.Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer[J].World journal of gastroenterology : WJG,2014,20(21):6691-6697.

[20]JIN Shi-dai,LU Kai-hua,SHU Yong-qian.Clinical study on bevacizumab combined with chemotherapy for treatment of advanced colorectal cancer[J].Journal of Clinical and Experimental Medicine,2012(24):1931-1932,1935.